StockData
Nu Skin Enterprises, Inc. logo

Nu Skin Enterprises, Inc. (NUS) stock

NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3070% below fair value
$3.87+0.09 (+2.38%)

Close on Nov 18, 2026Market cap $188.38MP/E –Yield –

Nu Skin Enterprises revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Nu Skin Enterprises's revenue for the twelve months ending Sep 30, 2026 was $1.32B, down 15.3% year over year. For fiscal 2025 it was $1.49B, down 14.3% from the year before. Over ten years it grew -4.1% a year on average. The highest annual figure on record is $3.18B in fiscal 2013.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.49B-14.3%
FY2024Dec 31, 2024$1.73B-12.0%
FY2023Dec 31, 2023$1.97B-11.5%
FY2022Dec 31, 2022$2.23B-17.4%
FY2021Dec 31, 2021$2.70B+4.4%
FY2020Dec 31, 2020$2.58B+6.7%
FY2019Dec 31, 2019$2.42B-9.7%
FY2018Dec 31, 2018$2.68B+17.5%
FY2017Dec 31, 2017$2.28B+3.2%
FY2016Dec 31, 2016$2.21B-1.7%
FY2015Dec 31, 2015$2.25B-12.5%
FY2014Dec 31, 2014$2.57B-19.1%
FY2013Dec 31, 2013$3.18B+49.0%
FY2012Dec 31, 2012$2.13B+24.0%
FY2011Dec 31, 2011$1.72B+11.9%
FY2010Dec 31, 2010$1.54B+15.5%
FY2009Dec 31, 2009$1.33B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$311.01M-14.6%
Q2 FY2026Jun 30, 2026$320.11M-17.1%
Q1 FY2026Mar 31, 2026$320.61M-12.0%
Q4 FY2025Dec 31, 2025$370.32M-16.9%
Q3 FY2025Sep 30, 2025$364.21M-15.3%
Q2 FY2025Jun 30, 2025$386.14M-12.1%
Q1 FY2025Mar 31, 2025$364.49M-12.7%
Q4 FY2024Dec 31, 2024$445.55M-8.8%
Q3 FY2024Sep 30, 2024$430.15M-13.8%
Q2 FY2024Jun 30, 2024$439.08M-12.2%
Q1 FY2024Mar 31, 2024$417.31M-13.3%
Q4 FY2023Dec 31, 2023$488.64M-6.5%
Q3 FY2023Sep 30, 2023$498.77M-7.3%
Q2 FY2023Jun 30, 2023$500.26M-10.8%
Q1 FY2023Mar 31, 2023$481.46M-20.4%
Q4 FY2022Dec 31, 2022$522.34M-22.4%
Q3 FY2022Sep 30, 2022$537.81M-16.1%
Q2 FY2022Jun 30, 2022$560.62M-20.4%
Q1 FY2022Mar 31, 2022$604.90M-10.7%
Q4 FY2021Dec 31, 2021$673.44M-10.0%
Q3 FY2021Sep 30, 2021$641.15M-8.8%
Q2 FY2021Jun 30, 2021$704.06M+15.0%
Q1 FY2021Mar 31, 2021$677.03M+30.7%
Q4 FY2020Dec 31, 2020$748.19M+28.3%
Q3 FY2020Sep 30, 2020$703.35M+19.2%
Q2 FY2020Jun 30, 2020$612.37M-1.8%
Q1 FY2020Mar 31, 2020$518.03M-16.9%
Q4 FY2019Dec 31, 2019$583.36M-14.6%
Q3 FY2019Sep 30, 2019$589.93M-12.6%
Q2 FY2019Jun 30, 2019$623.50M-11.5%
Q1 FY2019Mar 31, 2019$623.62M+1.2%
Q4 FY2018Dec 31, 2018$683.29M+2.6%
Q3 FY2018Sep 30, 2018$675.31M+19.8%
Q2 FY2018Jun 30, 2018$704.19M+28.0%
Q1 FY2018Mar 31, 2018$616.22M+23.5%
Q4 FY2017Dec 31, 2017$666.20M+25.4%
Q3 FY2017Sep 30, 2017$563.70M–
Q2 FY2017Jun 30, 2017$550.10M–
Q1 FY2017Mar 31, 2017$499.10M–
Q4 FY2016Dec 31, 2016$531.33M–

More Nu Skin Enterprises figures

See a number that looks wrong?